2342 — Trans Genic Income Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsBalancedMicro CapNeutral

Annual income statement for Trans Genic, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,675	11,047	11,046	12,577	11,430
Cost of Revenue
Gross Profit	1,498	1,780	2,777	3,836	1,995
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	8,458	11,276	10,373	11,264	12,027
Operating Profit	217	-230	674	1,312	-598
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	203	-250	695	2,768	-332
Provision for Income Taxes
Net Income After Taxes	202	-441	542	1,860	-440
Minority Interest
Net Income Before Extraordinary Items
Net Income	202	-441	546	1,876	-410
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	202	-441	546	1,876	-410
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	19	-5.6	45	76.6	-0.013
Dividends per Share
Special Dividends per Share